KLK3 and prostate carcinoma: Common examples include Prostate-specific antigen (PSA), which is used to monitor disease status in patients with prostate cancer (60, 61) and International normalized ration (INR) or prothrombin time (PT) to evaluate anticoagulative treatment response (62).